LycoRed Lyc-O-Fem slow-release genistein, lycopene and vitamin D3 formulation

LycoRed has launched Lyc-O-Fem, a slow-release formulation containing genistein in a proprietary composition for bone health. The formulation is claimed to also alleviate menopause symptoms.

Lyc-O-Fem is the first in the company’s line of products combining slow-release technology with genistein, tomato lycopene and vitamin D3. The company says all three are clinically proven nutrients to support bone health.

The genistein in the product is a phytoestrogen derived from Sophora japonica, the Japanese pagoda tree, and is standardised to 98% purity and specially formulated for slow release. The compound has been shown in research studies to support bone health and reduce vasomotor symptoms. Studies back the positive effect of genistein on bone metabolism in post-menopausal women, without the harmful estrogenic activity.

However, genistein is rapidly metabolised, requiring a twice-daily administration of the supplement. The slow-release technology in the company’s preparation provides a continuous exposure, allowing once-a-day supplementation.

Lycopene is a bright-red carotenoid pigment; the formulation contains lycopene from an all-natural extract of tomatoes. To develop a strain of non-genetically modified tomatoes rich in lycopene - up to four times the amount found in regular tomatoes - conventional crossbreeding methods were used and a proprietary method for extracting the tomato lycopene from these tomatoes was developed. The formulation is available as a (drum-to-hopper) premix, in hard-shell capsules or as a bulk or fully packed product.